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ABSTRACT  
Antibiotic resistance is undermining public health; it is imperative that new classes of antibiotics are discovered and 
developed by companies and academic institutions alike. Previous research by this group used the excellent adaptability 
of N-heterocyclic carbene (NHC)-silver compounds, which allowed for the discovery of the lead compound 1,3-dibenzyl-
4,5-diphenylimidazol-2-ylidene silver(I) acetate (SBC3) [1]. SBC3 breaks the methicillin-resistance in Staphylococcus 
aureus (MRSA) [2] and has proven effective in in vivo tests using Galleria mellonella [3]. More recently, encouraging 
parts of the antibiotic mechanism of SBC3 were discovered, which underlines the ability of SBC3 to break antibiotic 
resistance patterns [4]. And SBC3 was tested successfully against biofilms in vitro and against MRSA in-infected mice 
in vivo [5]. In addition, a telescoped continuous flow route was developed which surpassed the previous batch approach. 
This provided for a scalable means to afford the targets in higher yield. 
 
 
STRUCTURE OF THE ANTIBIOTIC DRUG CANDIDATE SBC3 
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